Peripartum cardiomyopathy - a new treatment option by inhibition of prolactin secretion

被引:41
作者
Jahns, Boriana G. [1 ,2 ]
Stein, Werner [1 ]
Hilfiker-Kleiner, Denise [3 ]
Pieske, Burkert [4 ,5 ]
Emons, Guenter [1 ]
机构
[1] Univ Gottingen, Dept Gynecol & Obstet, D-37075 Gottingen, Germany
[2] Univ Bern, Dept Obstet & Gynecol, Inselspital, Univ Hosp, CH-3000 Bern, Switzerland
[3] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany
[4] Univ Gottingen, Ctr Internal Med, D-37075 Gottingen, Germany
[5] Univ Hosp, Ctr Internal Med, Graz, Austria
关键词
bromocriptine; cathepsin D; peripartum cardiomyopathy; prolactin;
D O I
10.1016/j.ajog.2008.06.051
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.
引用
收藏
页码:e5 / e6
页数:2
相关论文
共 10 条
[1]   Improved outcomes in peripartum cardiomyopathy with contemporary [J].
Amos, Ankie M. ;
Jaber, Wissam. A. ;
Russell, Stuart D. .
AMERICAN HEART JOURNAL, 2006, 152 (03) :509-513
[2]   Incidence, mortality, and racial differences in peripartum cardiomyopathy [J].
Brar, Somjot S. ;
Khan, Steven S. ;
Sandhu, Gagandeep K. ;
Jorgensen, Michael B. ;
Parikh, Neil ;
Hsu, Jin-Wen Y. ;
Shen, Albert Yuh-Jer .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (02) :302-304
[3]   Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis [J].
Corbacho, AM ;
de las Escalera, GM ;
Clapp, C .
JOURNAL OF ENDOCRINOLOGY, 2002, 173 (02) :219-238
[4]  
Fett James D, 2002, Minn Med, V85, P46
[5]   A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy [J].
Hilfiker-Kleiner, Denise ;
Kaminski, Karol ;
Podewski, Edith ;
Bonda, Tomasz ;
Schaefer, Arnd ;
Sliwa, Karen ;
Forster, Olaf ;
Quint, Anja ;
Landmesser, Ulf ;
Doerries, Carola ;
Luchtefeld, Maren ;
Poli, Valeria ;
Schneider, Michael D. ;
Balligand, Jean-Luc ;
Desjardins, Fanny ;
Ansari, Aftab ;
Struman, Ingrid ;
Nguyen, Ngoc Q. N. ;
Zschemisch, Nils H. ;
Klein, Gunnar ;
Heusch, Gerd ;
Schulz, Rainer ;
Hilfiker, Andres ;
Drexler, Helmut .
CELL, 2007, 128 (03) :589-600
[6]   Acute onset of severe dilated cardiomyopathy during Bromocriptine therapy [J].
Kaushik, P ;
Vatsavai, SR ;
Banda, VR ;
Sanghi, PK ;
Ahmad, M ;
Kaushik, R .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (7-8) :1219-1221
[7]   Peripartum cardiomyopathy. [J].
Reimold, SC ;
Rutherford, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (21) :1629-1630
[8]   Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1 [J].
Sliwa, K ;
Skudicky, D ;
Bergemann, A ;
Candy, G ;
Puren, A ;
Sareli, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :701-705
[9]   Peripartum cardiomyopathy [J].
Sliwa, Karen ;
Fett, James ;
Elkayam, Uri .
LANCET, 2006, 368 (9536) :687-693
[10]   The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-κB [J].
Tabruyn, SP ;
Sorlet, CM ;
Rentier-Delrue, F ;
Bours, V ;
Weiner, RI ;
Martial, JA ;
Struman, I .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (09) :1815-1823